You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 102 No. 8, August 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (30)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Surgical Treatments of Proliferative Vitreoretinopathy

Alex E. Jalkh, MD; Marcos P. Avila, MD; Charles L. Schepens, MD; Claudio Azzolini, MD; Joseph E. Duncan, MA; Clement L. Trempe, MD

Arch Ophthalmol. 1984;102(8):1135-1139.


Abstract

• Four hundred ten eyes with retinal detachment and proliferative vitreoretinopathy underwent closed vitrectomy with membrane peeling, scleral buckling, and intraocular air injection. The retina was reattached in 243 eyes (59.3%). Useful vision was attained in 223 eyes. The preoperative proliferative vitreoretinopathy was clinically graded in six groups of increasing severity (C-1, C-2, C-3, D-1, D-2, D-3). From grades C-2 to D-3, a significant trend related a decreased rate of retinal reattachment with increased severity. However, grade C-1 showed a significantly lower success rate than did grade C-2. Scleral buckling alone may be the treatment of choice in grade C-1 eyes. Grade D-3 eyes had the worst anatomic and functional results. Preoperatively, there was a significant relationship between increasing severity of proliferative vitreoretinopathy and frequency of aphakia, and aphakic eyes showed a significantly lower rate of retinal reattachment than did phakic eyes.



Author Affiliations

From the Eye Research Institute of Retina Foundation and Retina Associates, Boston (Drs Jalkh, Avila, Schepens, Azzolini, and Trempe and Mr Duncan), and the Department of Ophthalmology, American University of Beirut (Lebanon) Medical Center (Dr Jalkh). Dr Avila is now with the Vitreoretinal Unit of the Instituto de Olhos de Goiania (Brazil).


Footnotes

Accepted for publication Nov 23, 1984.

Reprint requests to the Library, Eye Research Institute, 20 Staniford St, Boston, MA 02114 (Dr Jalkh).

J. Wallace McMeel, MD, H. MacKenzie Freeman, MD, Ronald C. Pruett, MD, Felipe I. Tolentino, MD, and Tatsuo Hirose, MD, allowed us to use their cases for this study.

This investigation was supported in part by the Massachusetts Lions Eye Research Fund, Inc.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Perfluoropropane Gas, Modified Panretinal Photocoagulation, and Vitrectomy in the Management of Severe Proliferative Vitreoretinopathy
Fisher et al.
Arch Ophthalmol 1988;106:1255-1260.
ABSTRACT  

Fluid-Gas Exchange and Photocoagulation After Vitrectomy: Indications, Technique, and Results
Blumenkranz et al.
Arch Ophthalmol 1986;104:291-296.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.